Finally, we confirmed an up-regulation of the pro-inflammatory chemokine CXCL10 which is expressed by various cancer cell types and influences tumour progression through the recruitment of specific immune cell types into the tumour microenvironment, and has potential as an immunotherapeutic approach [36], [37]. Here, CXCL10 is linked to cancer.